Differences in the association of inflammation and tryptophan with depressive symptoms between white and non-white chronic dialysis patients

Gertrud L. Haverkamp, Wim L. Loosman, Robbert W. Schouten, Casper F. Franssen, Ido P. Kema, Merel van Diepen, Friedo W. Dekker, Carl E. Siegert, Adriaan Honig

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Objective Possibly, different biochemical parameters are involved in the development of depressive symptoms in white and non-white dialysis patients. We examined whether the association between inflammation and depressive symptoms and between tryptophan and depressive symptoms differs between white and non-white dialysis patients and whether the association between inflammation and depressive symptoms is mediated by tryptophan degradation along the kynurenine pathway in both groups. Method Depressive symptoms were measured with the BDI-II. HsCRP, IL-1β, IL-6, IL-10, and TNFα and tryptophan and its degradation products kynurenine and 3-hydroxykynurenine were measured in 270 white and 220 non-white patients. Results The presence of depressive symptoms was significantly higher in non-white patients (51%) than in white patients (37%) (P < 0.01). Among white patients, HsCRP was significantly associated with depressive symptoms (β = 0.6 (95% CI: 0.1–1.2)). Among non-white patients, significant associations with depressive symptoms were found for both HsCRP (β = 1.0 (95% CI: 0.1–2.0)) and IL-6 (β = 2.6 (95% CI: 0.8–4.4)). Tryptophan levels were only significantly associated with depressive symptoms in non-white patients (β = − 0.3 (95% CI: − 0.4–− 0.1)). Tryptophan degradation along the kynurenine pathway did not mediate the association between inflammatory markers and depressive symptoms in either group. Conclusion Our results indicate that for white and non-white dialysis patients different biochemical parameters are associated with depressive symptoms.
Original languageEnglish
Pages (from-to)76-82
JournalGeneral Hospital Psychiatry
Volume50
DOIs
Publication statusPublished - 2018

Cite this

Haverkamp, Gertrud L. ; Loosman, Wim L. ; Schouten, Robbert W. ; Franssen, Casper F. ; Kema, Ido P. ; van Diepen, Merel ; Dekker, Friedo W. ; Siegert, Carl E. ; Honig, Adriaan. / Differences in the association of inflammation and tryptophan with depressive symptoms between white and non-white chronic dialysis patients. In: General Hospital Psychiatry. 2018 ; Vol. 50. pp. 76-82.
@article{2dd6b698819f49528b48b6b66c7c7e23,
title = "Differences in the association of inflammation and tryptophan with depressive symptoms between white and non-white chronic dialysis patients",
abstract = "Objective Possibly, different biochemical parameters are involved in the development of depressive symptoms in white and non-white dialysis patients. We examined whether the association between inflammation and depressive symptoms and between tryptophan and depressive symptoms differs between white and non-white dialysis patients and whether the association between inflammation and depressive symptoms is mediated by tryptophan degradation along the kynurenine pathway in both groups. Method Depressive symptoms were measured with the BDI-II. HsCRP, IL-1β, IL-6, IL-10, and TNFα and tryptophan and its degradation products kynurenine and 3-hydroxykynurenine were measured in 270 white and 220 non-white patients. Results The presence of depressive symptoms was significantly higher in non-white patients (51{\%}) than in white patients (37{\%}) (P < 0.01). Among white patients, HsCRP was significantly associated with depressive symptoms (β = 0.6 (95{\%} CI: 0.1–1.2)). Among non-white patients, significant associations with depressive symptoms were found for both HsCRP (β = 1.0 (95{\%} CI: 0.1–2.0)) and IL-6 (β = 2.6 (95{\%} CI: 0.8–4.4)). Tryptophan levels were only significantly associated with depressive symptoms in non-white patients (β = − 0.3 (95{\%} CI: − 0.4–− 0.1)). Tryptophan degradation along the kynurenine pathway did not mediate the association between inflammatory markers and depressive symptoms in either group. Conclusion Our results indicate that for white and non-white dialysis patients different biochemical parameters are associated with depressive symptoms.",
author = "Haverkamp, {Gertrud L.} and Loosman, {Wim L.} and Schouten, {Robbert W.} and Franssen, {Casper F.} and Kema, {Ido P.} and {van Diepen}, Merel and Dekker, {Friedo W.} and Siegert, {Carl E.} and Adriaan Honig",
year = "2018",
doi = "10.1016/j.genhosppsych.2017.10.003",
language = "English",
volume = "50",
pages = "76--82",
journal = "General Hospital Psychiatry",
issn = "0163-8343",
publisher = "Elsevier Inc.",

}

Differences in the association of inflammation and tryptophan with depressive symptoms between white and non-white chronic dialysis patients. / Haverkamp, Gertrud L.; Loosman, Wim L.; Schouten, Robbert W.; Franssen, Casper F.; Kema, Ido P.; van Diepen, Merel; Dekker, Friedo W.; Siegert, Carl E.; Honig, Adriaan.

In: General Hospital Psychiatry, Vol. 50, 2018, p. 76-82.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Differences in the association of inflammation and tryptophan with depressive symptoms between white and non-white chronic dialysis patients

AU - Haverkamp, Gertrud L.

AU - Loosman, Wim L.

AU - Schouten, Robbert W.

AU - Franssen, Casper F.

AU - Kema, Ido P.

AU - van Diepen, Merel

AU - Dekker, Friedo W.

AU - Siegert, Carl E.

AU - Honig, Adriaan

PY - 2018

Y1 - 2018

N2 - Objective Possibly, different biochemical parameters are involved in the development of depressive symptoms in white and non-white dialysis patients. We examined whether the association between inflammation and depressive symptoms and between tryptophan and depressive symptoms differs between white and non-white dialysis patients and whether the association between inflammation and depressive symptoms is mediated by tryptophan degradation along the kynurenine pathway in both groups. Method Depressive symptoms were measured with the BDI-II. HsCRP, IL-1β, IL-6, IL-10, and TNFα and tryptophan and its degradation products kynurenine and 3-hydroxykynurenine were measured in 270 white and 220 non-white patients. Results The presence of depressive symptoms was significantly higher in non-white patients (51%) than in white patients (37%) (P < 0.01). Among white patients, HsCRP was significantly associated with depressive symptoms (β = 0.6 (95% CI: 0.1–1.2)). Among non-white patients, significant associations with depressive symptoms were found for both HsCRP (β = 1.0 (95% CI: 0.1–2.0)) and IL-6 (β = 2.6 (95% CI: 0.8–4.4)). Tryptophan levels were only significantly associated with depressive symptoms in non-white patients (β = − 0.3 (95% CI: − 0.4–− 0.1)). Tryptophan degradation along the kynurenine pathway did not mediate the association between inflammatory markers and depressive symptoms in either group. Conclusion Our results indicate that for white and non-white dialysis patients different biochemical parameters are associated with depressive symptoms.

AB - Objective Possibly, different biochemical parameters are involved in the development of depressive symptoms in white and non-white dialysis patients. We examined whether the association between inflammation and depressive symptoms and between tryptophan and depressive symptoms differs between white and non-white dialysis patients and whether the association between inflammation and depressive symptoms is mediated by tryptophan degradation along the kynurenine pathway in both groups. Method Depressive symptoms were measured with the BDI-II. HsCRP, IL-1β, IL-6, IL-10, and TNFα and tryptophan and its degradation products kynurenine and 3-hydroxykynurenine were measured in 270 white and 220 non-white patients. Results The presence of depressive symptoms was significantly higher in non-white patients (51%) than in white patients (37%) (P < 0.01). Among white patients, HsCRP was significantly associated with depressive symptoms (β = 0.6 (95% CI: 0.1–1.2)). Among non-white patients, significant associations with depressive symptoms were found for both HsCRP (β = 1.0 (95% CI: 0.1–2.0)) and IL-6 (β = 2.6 (95% CI: 0.8–4.4)). Tryptophan levels were only significantly associated with depressive symptoms in non-white patients (β = − 0.3 (95% CI: − 0.4–− 0.1)). Tryptophan degradation along the kynurenine pathway did not mediate the association between inflammatory markers and depressive symptoms in either group. Conclusion Our results indicate that for white and non-white dialysis patients different biochemical parameters are associated with depressive symptoms.

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85031802566&origin=inward

UR - https://www.ncbi.nlm.nih.gov/pubmed/29065338

U2 - 10.1016/j.genhosppsych.2017.10.003

DO - 10.1016/j.genhosppsych.2017.10.003

M3 - Article

VL - 50

SP - 76

EP - 82

JO - General Hospital Psychiatry

JF - General Hospital Psychiatry

SN - 0163-8343

ER -